Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes

NCT00622752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: EVT 302, 10 mg
DRUG: placebo
DRUG: Nicotine replacement therapy (NRT)
DEVICE: NRT placebo

Sponsor

Evotec Neurosciences GmbH